Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S S Lund

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Diabetologia|February 5, 2013
Metformin and mortalityS S Lund
Scandinavian Journal of Medicine & Science in Sports|August 5, 2011
High injury incidence in TeamGym competition: a prospective cohort studyS S Lund, G Myklebust
Sykepleien|August 6, 1984
[Stimulation group for mentally handicapped children]M G Blom, S S Lund
European Journal of Endocrinology|October 11, 2014
Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind placebo-controlled studyK D Hove, C Brøns, K Færch, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 30, 2001
Preventing diabetic nephropathy: an auditH P Hansen, S S Lund, P Rossing, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 21, 2009
Sustained postprandial decrease in plasma levels of LDL cholesterol in patients with type-2 diabetes mellitusS S Lund, M Petersen, M Frandsen, et al.
Diabetologia|November 26, 2011
Impact of circulating vaspin levels on metabolic variables in elderly twinsK Hida, P Poulsen, S Teshigawara, et al.
Diabetologia|September 27, 2012
Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled studyK D Hove, C Brøns, K Færch, et al.
Diabetes, Obesity & Metabolism|March 8, 2013
Preferences for medication attributes among patients with type 2 diabetes mellitus in the UKH L Gelhorn, S M Stringer, A Brooks, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trialS S Lund, L Tarnow, C D A Stehouwer, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Diabetologia|February 5, 2013
Metformin and mortalityS S Lund
Scandinavian Journal of Medicine & Science in Sports|August 5, 2011
High injury incidence in TeamGym competition: a prospective cohort studyS S Lund, G Myklebust
Sykepleien|August 6, 1984
[Stimulation group for mentally handicapped children]M G Blom, S S Lund
European Journal of Endocrinology|October 11, 2014
Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind placebo-controlled studyK D Hove, C Brøns, K Færch, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 30, 2001
Preventing diabetic nephropathy: an auditH P Hansen, S S Lund, P Rossing, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 21, 2009
Sustained postprandial decrease in plasma levels of LDL cholesterol in patients with type-2 diabetes mellitusS S Lund, M Petersen, M Frandsen, et al.
Diabetologia|November 26, 2011
Impact of circulating vaspin levels on metabolic variables in elderly twinsK Hida, P Poulsen, S Teshigawara, et al.
Diabetologia|September 27, 2012
Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled studyK D Hove, C Brøns, K Færch, et al.
Diabetes, Obesity & Metabolism|March 8, 2013
Preferences for medication attributes among patients with type 2 diabetes mellitus in the UKH L Gelhorn, S M Stringer, A Brooks, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trialS S Lund, L Tarnow, C D A Stehouwer, et al.
Pageof 2